Strong match on stage (pre-seed/early-stage), sector (techbio for drug discovery AI), and funding structure (equity-free, non-dilutive preferred). Location in Basel is outside applicant's Île-de-France priority, though Swiss accelerators are EU-accessible. Specific support (compute credits, biopharma network mentorship) not detailed in available snippet.